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Abstract
Purpose: Repeat computed tomography (CT) simulation is problematic because of additional
expense of clinic resources, patient inconvenience, additional radiation exposure, and treatment
delay. We investigated the factors and clinical impact of unplanned CT resimulations in our
network.
Methods and Materials: We used the billing records of 18,170 patients treated at 5 clinics. A total
of 213 patients were resimulated before their ﬁrst treatment. The disease site, location, use of 4dimensional CT (4DCT), contrast, image fusion, and cause for resimulation were recorded. Odds
ratios determined statistical signiﬁcance.
Results: Our total rate of resimulation was 1.2%. Anal/colorectal (P < .001) and head and neck
(P < .001) disease sites had higher rates of resimulation. Brain (P Z .001) and lung/thorax
(P Z .008) had lower rates of resimulation. The most common causes for resimulation were setup
change (11.7%), change in patient anatomy (9.8%), and rectal ﬁlling (8.5%). The resimulation rate
for 4DCTs was 3.03% compared with 1.0% for non-4DCTs (P < .001). Median time between
simulations was 7 days.
Conclusions: The most common sites for resimulation were anal/colorectal and head and neck,
largely because of change in setup or changes in anatomy. The 4DCT technique correlated with
higher resimulation rates. The resimulation rate was 1.2%, and median treatment delay was 7 days.
Further studies are warranted to limit the rate of resimulation.
Ó 2019 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation
Oncology. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Introduction
Modern radiation treatment planning primarily uses
computed tomography (CT) imaging for target delineation. A resimulation is when a repeat CT scan is necessary
after the initial planning scan. Some resimulations are
planned in the middle of treatment as a result of tumor
shrinkage or patient weight loss, as is commonly seen in
head and neck (H&N) treatment.1 An unplanned resimulation occurs when there is an unforeseen problem
with the initial planning scan before the initiation of
treatment delivery, thus requiring a repeat simulation.
Causes of resimulation include but are not limited to
bladder or rectal ﬁlling, exaggerated respiratory motion,
image artifact, inappropriate treatment setup, and change
in patient anatomy.
Achieving the desired reproducible anatomy of a patient, both externally and internally, can be difﬁcult
because of patient factors or noncompliance.2 For
instance, patients with pelvic tumors are often simulated
with a full bladder and empty rectum to move the small
bowel out of the ﬁeld and allow for a consistent treatment
setup. Variations in bladder ﬁlling and inﬂuence of bowel
preparation are well documented for pelvic tumors such
as in the prostate, gynecologic malignancies, and rectal
cancer.3-5 Inappropriate bladder/rectal ﬁlling on the initial
CT can require a resimulation to optimize dosimetry in
treatment planning. Beyond patient-related factors, complex setups and suboptimal image quality may necessitate
a resimulation. For example, the respiratory motion
accounted for by a 4-dimensional CT (4DCT) adds
complexity to the CT simulation acquisition and may
result in image artifact from irregular respiration.6,7 Ultimately, the causes of resimulation are multifactorial and
can be unpredictable.
In addition to added cost, time, and radiation exposure,
resimulations may cause a delay in planning and treatment, which has been associated with poorer survival
throughout various disease sites.8-11 To our knowledge no
publications have quantiﬁed unplanned resimulations.
Therefore we analyzed the incidence of resimulations and
their precipitating causes within our network.

Methods and Materials
In this institutional review boardeexempt quality
assurance (QA) study, we used the billing records of
18,170 consecutive cases treated within our integrated
cancer network from August 2005 to December 2017 to
identify all the instances of resimulation performed within
that period. Patients were treated at 5 radiation oncology
clinics: 4 community practices and 1 academic setting.
There were a total of 11 treating physicians, all of whom
still practice in our department. Additionally, the system
director of the network and clinical operation physician
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for each clinic remained the same through all the years
included in this study. We conducted a search using the
departmental code for resimulation in our electronic
medical record (Mosaiq-Elekta, Version 2.64; Elekta,
Inc). A total of 453 patients were resimulated at least
1 day after the initial simulation. To eliminate planned
resimulation, the following were excluded: patients who
were resimulated after the treatment start date and any
planned resimulation such as after prostate seed placement or after high-dose-rate balloon breast brachytherapy
(n Z 240). Ultimately, 213 patients underwent an unplanned resimulation before ﬁrst treatment. The disease
site and the cause leading to resimulation were recorded
as detailed in Tables 1 and 2. The additional factors
evaluated included the treatment clinic, use of 4DCT, use
of intravenous/oral (IV/PO) contrast, and positron emission tomography (PET)-CT image fusion. The time between initial CT simulation and resimulation was also
recorded.
For the statistical analysis, we calculated the percentages for each of the resimulation parameters being evaluated: disease site, common causes, 4DCT, IV/PO
contrast, and PET-CT fusion. We then conducted a univariate binomial regression analysis for each disease site
delineated via odds ratios using c2 testing for statistical
signiﬁcance. The control used for our statistics was the
total number of patients treated for each disease site.
Microsoft Excel 2010 was used for statistical analysis.

Results
The total rate of resimulation at the 5 radiation
oncology clinics evaluated was 1.2%. Anal/colorectal
(P < .001; odds ratio [OR], 2.72; conﬁdence interval [CI],
1.73-4.30) and head and neck (P < .001; OR, 2.67; CI,
1.70-4.22) disease sites were associated with signiﬁcantly
higher rates of resimulation. Brain (P Z .001; OR, 0.38;
CI, 0.22-0.66) and lung/thorax (P Z .008; OR, 0.48; CI,
0.28-0.82) were associated with signiﬁcantly lower rates
of resimulation. No other disease site was found to be
statistically signiﬁcant for being either more or less at risk
for resimulation. Each disease site’s reported resimulation
rates and the most common corresponding cause for each
site are listed in Table 1. Eighty percent of cases reviewed
provided sufﬁcient documentation to elicit the cause for
resimulation. The most common documented causes
included setup change (11.7%), change in patient anatomy between initial simulation and treatment (9.8%), and
rectal ﬁlling (8.5%). The 3 most common causes of a
setup change were repositioning of the arm, head/feet
ﬁrst, and head extension. The causes of resimulation and
the percentage of time each reason occurred are displayed
in Table 2.
Factors evaluated included the use of 4DCT, IV/PO
contrast, and PET/CT fusion. The 4DCT resimulation rate

718

A. Metzger et al

Table 1
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Each disease site, their resimulation rate, and most common cause

Disease site

Resimulation
rate

No. of patients Total no. of P value and OR (95% CI) Most common cause
resimulated
patients

Anal/colorectal

3.13%

21

670

Head and neck

3.07%

21

683

Sarcoma
Skin

2.91%
2.05%

5
9

172
440

Hepatobiliary
Bone metastases
Gynecologic
Breast
Prostate
Esophagus/stomach
Pancreas
Lung/thorax

1.87%
1.70%
1.38%
1.14%
1.04%
0.89%
0.85%
0.64%

11
21
9
39
37
3
3
14

589
1233
654
3407
3556
336
351
2202

Brain

0.53%

14

2659

Lymphoma/multiple
myeloma

0.32%

2

627

P < .001
OR, 2.72, 1.73-4.30
P < .001
OR, 2.67, 1.70 -4.22
NS
NS

NS
NS
NS
NS
NS
NS
NS
P Z .008
OR, 0.48, 0.28-0.82
P Z .001
OR, 0.38, 0.22-0.66
NS

Supine vs prone
1a. Chemotherapy ﬁrst
1b. Change in anatomy*
Setup change
1a. Radiation therapy plan
change
1b. Bolus placement*
Respiratory motion
Setup change
CT scan length adjustment
Setup change
Rectal ﬁlling
Change in anatomyy
Stomach ﬁlling
Respiratory motion
Stereotactic radiosurgery
frame displacement
1a. Chemotherapy ﬁrst
1b. Bolus placement*

Abbreviations: CT Z computed tomography; NS Z nonsigniﬁcant; OR Z odds ratio.
* Tie result.
y
Among known causes.

Table 2 The occurrence rate of the most common reasons
for resimulation calculated out of the total number of
resimulations
Reason for
resimulation

Rate of
occurrence

No. of
patients

Unknown
Setup change
Change in anatomy
Rectal ﬁlling
Immobilization devices
Other
Prone/supine
CT scan length adjustment
Change in RT plan
Chemotherapy/lupron ﬁrst
Respiratory motion
Bladder ﬁlling
Vacuum bag malfunction
Imaging artifact
Bolus placement
SRS frame displacement
Stomach ﬁlling
Fusion difﬁculty

20.19%
11.73%
9.86%
8.45%
6.57%
6.57%
4.69%
4.69%
4.69%
4.22%
3.76%
2.82%
2.82%
2.35%
1.88%
1.88%
1.88%
0.47%

43
25
21
18
14
14
10
10
10
9
8
6
6
5
4
4
4
1

Abbreviations: CT Z computed tomography; RT Z radiation
therapy; SRS Z stereotactic radiosurgery.

was 3.03% compared with 1.0% for non-4DCT
(P < .001; OR, 2.64; CI, 1.67-4.16). Use of IV/PO
contrast or PET/CT fusion did not reach statistical signiﬁcance. There was also no difference in rates of resimulation between academic and community setting.
Median time between initial simulation and resimulation
was 7 days (range, 1-143). Excluding those who received
systemic therapy before resimulation, the median time
between initial simulation and resimulation was 6 days
(range, 1-29).

Discussion
Unforeseen repeat CT simulations are an inevitable
part of every radiation oncology practice. Within our
network, the overall rate of resimulation was relatively
low at 1.2%, although because to our knowledge this is
the ﬁrst study of its kind, no published data exist for
comparison. The possible treatment delay, added cost,
and patient inconvenience from resimulations merit efforts to mitigate their occurrence. Although small, additional radiation exposure from a resimulation also
warrants an attempt to decrease its incidence.12 Some
resimulations will be unavoidable, but many can be
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limited through a better understanding of the more troublesome disease sites and common causes.
Anal/colorectal and H&N disease sites had a statistically signiﬁcant higher rate of resimulation. The simulation for treatment of pelvic and gastroenterological
malignancies involves detailed decision making for each
individual case. Common considerations include bowel
sparing techniques (prone vs supine), bolus requirement,
genitalia sparing, patient comfort, bladder ﬁlling, and use
of IV/PO contrast. For example, prone positioning with a
belly board allows for improved bowel sparing; however,
it may present greater interfraction variability. A “froglegged” supine position decreases some of the skin folds
to mitigate the amount of radiation dermatitis.13,14 Taking
into account setup and internal dynamic factors, both anal
and colorectal radiation treatment could be considered at
risk for resimulation. The most common reason for resimulation in this patient subgroup was determining the
prone or supine position, likely to optimize bowel
sparing. Physicians may ﬁnd it beneﬁcial to scrutinize the
initial CT simulation for the presence of small bowel in
the treatment ﬁeld and, if needed, address this with a
change in the patient’s position.
H&N patients offer a unique management challenge
because they may have signiﬁcant anatomic changes
during the course of their treatment.15 Before the initiation
of therapy, these tumors are known to be aggressive, with
an in vitro potential doubling time as short as <6 days.16
In most patients a treatment delay of as little as 4 weeks
can lead to signiﬁcant tumor progression both in growth
of the primary as well as new lymph node metastases.17
The most common causes for resimulation in these patients were change in anatomy and change in plan to
receive chemotherapy ﬁrst. The aggressive nature of these
tumors can explain both of these causes for resimulation
and reﬂects the importance of starting treatment as soon
as possible.
The lung and brain disease sites were statistically
signiﬁcant for having lower rates of resimulation. Simulations for lung treatment plans vary considerably
depending on the deﬁnitive or palliative nature of the
case. This was not accounted for in this study and may
have led to a lower rate of resimulation because this is
less likely in simple palliative lung plans. However,
4DCT scans, used in nearly all deﬁnitive lung cases,
were found to have a statistically signiﬁcant higher
resimulation rate. Unsurprisingly, the most common
cause for resimulation in the lung subgroup was exaggerated respiratory motion, further indicating that most
deﬁnitive lung treatments are associated with a higher
resimulation rate. Brain treatment for either primary
brain tumors or brain metastases is similar in its setup for
each patient. Patients are simulated with a thermoplastic
mask or head frame for customized immobilization. The
lower rate of resimulation likely reﬂects the typical
standard approach to treatment.
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The most common known cause for resimulation was
change in setup, at 11.7% of the total resimulations.
Repositioning the patient was the most common cause for
resimulation in this category. For example, the simulation
for a breast patient usually involves the patient lying in a
supine position, on a wedge cushion, with the patient’s
arms overhead.18 The arm position sometimes requires
adjustment if it is in the treatment ﬁeld, which would
require a resimulation. H&N disease sites are simulated in
a supine position, with some sites requiring the head
extended to allow the oral cavity to be displaced from the
ﬁeld and the shoulders down to minimize the potential for
beam interference.19 However, sometimes the amount of
head extension is limited because of patient discomfort,
which could also lead to resimulation.20
An attempt to distinguish between random occurrences
and systemic processes as the culprit behind resimulation
was difﬁcult because what appears to be a random
occurrence can be inﬂuenced by a systematic process. For
instance, patients with prostate cancer are educated at the
time of consult and reminded the day before simulation,
with both verbal and written instructions, to have a full
bladder and empty rectum at time of simulation. However, as reﬂected in our study, this desired reproducible
anatomy is not always attainable for prostate simulations
and represents the number one cause for prostate resimulation. This patient factor/random occurrence still occurs despite a thorough QA program. This prompts the
question of whether additional measures can be taken to
improve the QA program. Dawdy et al21 recognized the
need for resimulation in many patients with prostate
cancer. This prompted them to improve patient preparedness through a randomized study evaluating a
multimedia patient education tool (YouTube video) in
addition to verbal reminders and ﬂyers. Patients indicated
they felt more prepared for their treatment, although there
was no statistical difference between the multimedia
group and verbal reminders/ﬂyereonly group in the
rescanning rate.21 Strategies to mitigate resimulations for
each disease site can be incorporated into ever-evolving
QA improvements.
It is important that clinics attempt to mitigate the rate
of resimulations and successful solutions be communicated to the radiation oncology community. We believe
additional QA steps integrated into the CT simulation
workﬂow at our institution may be beneﬁcial in
decreasing the rate of resimulations. The ﬁrst QA step is
performing a “time out” before a simulation. This will
allow the physician to familiarize the team with the patient while highlighting important details of the setup and
to communicate difﬁculties that may arise. In addition, it
ensures the orders for the simulation are accurate and will
allow the team members to voice concerns. A second
intervention would be the formulation of a physician
checklist that highlights important aspects for each site,
such as bladder/rectal ﬁlling, small bowel location, patient
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positioning, respiratory motion for 4DCTs, and so on.
These checklists will then be used to scrutinize certain
aspects of the CT simulation before the patient gets off the
table. Both interventions communicate to the team the
importance of the CT simulation and will help start a
discussion within a clinic and in the radiation oncology
community on potential solutions to help mitigate
resimulations.
In our study the median time between initial planning
and resimulation was 7 days. Limiting treatment delay to
improve both radiobiological and clinical outcomes has
been consistently projected in the literature. Malignancies
as aggressive as small cell lung cancer and as curable as
breast cancer have both been associated with poorer
outcomes if time to radiation therapy is not optimized.9,22
H&N and cervical tumors are likely the most described
diseases for which any delay in treatment can be detrimental to survival and can lead to higher rates of
locoregional recurrence in both deﬁnitive and adjuvant
settings.8,9 Regardless of the disease site, every effort
should be made to limit treatment delays.
Other important considerations regarding resimulations include the potential increased patient anxiety and
transportation burden that can arise with an additional
visit and repeat CT imaging. Anxiety at the start of any
radiation therapy treatment course is common.23,24 The
effects of treatment-related anxiety can contribute to fatigue, side effects, and decreased quality of life.25,26
Avoiding the additional anxiety and transportation costs
associated with a resimulation was a motivation in the
study on improving preparedness for initial simulations
for patients with prostate cancer discussed earlier.22
An additional consideration is the added radiation
exposure from a repeat CT scan.12 The CT scan increases
the dose to organs at risk outside the radiation ﬁeld and
could theoretically increase the risk of a secondary malignancy.27 Furthermore, close attention is required with a
4DCT simulation because these had a higher rate of
resimulation, and 4DCT scans can have a radiation dose 2
to 4 times higher than that of a conventional CT scan.28
However, obtaining a quality CT simulation is essential,
and this exposure is small compared with the total dose
delivered during a radiation course.
This study is limited by its retrospective nature and
selection bias therein. As described earlier, clinicians may
ﬁnd it difﬁcult to interpret the data because some causes
for resimulation were random occurrences, whereas others
were due to systemic errors, making attempts to discern
these causes challenging. In addition, the QA processes
integrated into our CT simulation workﬂow may differ
from those of other institutions, affecting the resimulation
rate and the balance between random versus systemic
causes. Although a detailed search through medical records was used to uncover causes of resimulations,
documented reasons were not available in 20% of resimulation cases. However, the most common disease sites
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of the unknown group were breast and prostate, which
was similar to the known group and thus is likely
consistent with the rest of our data.

Conclusions
To our knowledge this is the ﬁrst study to quantify the
rate of unplanned resimulation and the common reasons
they occur. At our institution the resimulation rate was
low at 1.2% and resulted in a median treatment delay of
7 days. Resimulations were most commonly needed for
anal/colorectal and H&N disease sites, largely because of
setup error or changes in anatomy. The data presented
here may be helpful in implementing QA strategies and
prospective studies to mitigate unplanned resimulations
and improve the overall quality of radiation treatment
delivery.
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